Short Interest in Hua Medicine (Shanghai) Ltd. (OTCMKTS:HUMDF) Drops By 22.0%

Hua Medicine (Shanghai) Ltd. (OTCMKTS:HUMDF) was the recipient of a significant drop in short interest in May. As of May 31st, there was short interest totalling 337,400 shares, a drop of 22.0% from the May 15th total of 432,400 shares. Based on an average daily volume of 0 shares, the days-to-cover ratio is presently ∞ days.

Hua Medicine (Shanghai) Price Performance

Shares of OTCMKTS HUMDF remained flat at C$0.20 during mid-day trading on Monday. Hua Medicine has a 1 year low of C$0.20 and a 1 year high of C$0.20. The company’s 50-day moving average price is C$0.20 and its two-hundred day moving average price is C$0.20.

Hua Medicine (Shanghai) Company Profile

Hua Medicine (Shanghai) Ltd. operates as a drug development company that focuses on therapies for the treatment of diabetes in China. It develops Dorzagliatin or HMS5552, an oral drug for the treatment of Type 2 Diabetes (T2D); and Dorzagliatin in combination with Metformin, Sitagliptin, and Empagliflozin for treatment of T2D.